You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Details for Patent: 4,755,534

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,755,534
Title: Propenylamines, pharmaceutical compositions containing them and their use as pharmaceuticals
Abstract:A compound of the formula: ##STR1## wherein the double bond is in the trans configuration and R.sub.1 is a radical of formula IIa, ##STR2## R.sub.2, R.sub.3, R.sub.5, R.sub.7 and R.sub.8 are each hydrogen, R.sub.4 is methyl, and R.sub.6 is a radical of formula IIIa where R.sub.11 is n-butyl, tertiary butyl or phenyl or a chemotherapeutically acceptable acid addition salt thereof; processes for their production, their use as pharmaceuticals and pharmaceutical compositions containing them.
Inventor(s): Stuetz; Anton (Maria Enzersdorf, AT)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/646,724
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,755,534
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,755,534

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,755,534

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland7656/79Aug 22, 1979

International Family Members for US Patent 4,755,534

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 10272   Start Trial
Australia 538928   Start Trial
Australia 6159280   Start Trial
Canada 1157023   Start Trial
Cyprus 1410   Start Trial
Germany 19375084   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.